Viewing Study NCT05724108


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-01-01 @ 2:16 AM
Study NCT ID: NCT05724108
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-24
First Post: 2023-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neuroendocrine Tumors
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module